9/10/2026
Rhelion Life Sciences launches stability program for ibogaine
Filament Health begins stability testing for IBEX011, a botanical ibogaine drug.
Topic archive
6 stories
9/10/2026
Filament Health begins stability testing for IBEX011, a botanical ibogaine drug.
9/10/2026
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
The move promotes open science and could influence future psychedelic research.
8/19/2026
Company aligns with U.S. efforts to advance ibogaine research.
8/6/2026
Mississauga man charged after fatal ibogaine ceremony in Waterloo Region.